Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest news from Datamonitor

July 28, 2008
Sales and Marketing Genentech, Roche

Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …

News

Pharma-Patient group relationships

July 24, 2008
Research and Development, Sales and Marketing industry relations, patient groups, pharma

In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …

Feature

Generics giant formed as Teva acquires Barr

July 24, 2008
Sales and Marketing generics

Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …

News

Roche acquires gene therapy specialists Mirus

July 24, 2008
Sales and Marketing

Roche has bought Mirus Bio for $125 million, a move which it believes will put it at the forefront of …

News

Pfizer thrives despite US slowdown

July 24, 2008
Sales and Marketing

Pfizer has posted strong second quarter results despite underwhelming performance from its US operations. Outside the US Pfizer's revenue rose …

News

National movement’ needed to tackle obesity

July 24, 2008

Local communities, businesses, charities and other groups need to come together in a 'national movement' in order to tackle the …

News

Witty outlines GSK’s new strategic priorities

July 24, 2008
Sales and Marketing GSK

News

Biometrics: a ‘cheat-proof’ exam?

July 21, 2008
Business Services, Sales and Marketing biometris, pharma, recruitment, sales

Feature

Latest news from Datamonitor

July 21, 2008
Sales and Marketing

Immunisation against S. aureus has potential in selected target groups Staphylococcus aureus bacteria have become a key concern in both …

News

Novartis shows strong Q2 growth

July 17, 2008
Sales and Marketing

Novartis has surpassed estimates for its second quarter performance, boosted by higher than expected sales of its flagship cardiovascular and …

News

AstraZeneca staff trained in new Code of Conduct

July 17, 2008
Medical Communications

AstraZeneca is training staff in a new Code of Conduct that aims to ensure employees at all levels and locations …

News

US pharma marketing Code updated

July 17, 2008
Medical Communications, Sales and Marketing

Dining out, staff training and medical education are among the major issues under the microscope in the US industry association …

News

GSK signs $1.5 billion insomnia collaboration

July 16, 2008
Sales and Marketing Actelion, GSK, insomnia

 GlaxoSmithKline has joined forces with Swiss biopharmaceutical company Actelion to bring a new insomnia treatment to market.The deal could be …

News

The PPRS: A Happy Compromise

July 16, 2008
Sales and Marketing

After more than a year of uncertainty and months of tense negotiation, the ABPI looks to have secured a very …

News

PPRS reaction

July 16, 2008
Research and Development, Sales and Marketing biotech

Aisling Burnand, chief executive of the biotech representative body the BIA welcomed the deal, saying she was pleased the "months …

News

Relief as pharma industry secures ‘pro-innovation’ UK pricing deal

July 16, 2008
Sales and Marketing ABPI, par

Agreement has been reached on a new UK medicines pricing deal which safeguards the industry's ability to set its own …

News

Roche suspended from ABPI

July 15, 2008
Sales and Marketing

Roche has been suspended from the ABPI for at least six months after being found guilty of bringing discredit on …

News

Marketing effectiveness: cloudy thinking won’t cut it

July 15, 2008
Sales and Marketing effectiveness, marketing

Over recent years the pharmaceutical industry has been unable to escape the mantra of return on investment (ROI). Investment in …

Feature

The World According To ..

July 14, 2008
Medical Communications, Sales and Marketing advertising, communications

What, in your opinion, is the current state of marketing in pharma? What a question. How do you measure the …

Feature

Latest news from Datamonitor

July 14, 2008
Sales and Marketing

Regulatory warning for anti-epileptic drugs presents greatest threat to non-epilepsy indicationsThe FDA is close to adding a black box warning …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025